Condition: Cognitive Impairment · Intracerebral Hemorrhage · Sponsor: Qinhuangdao Hospital of Traditional Chinese Medicine
This is a randomized, controlled clinical study conducted across multiple centers. The neurosurgical robot can be used to treat patients with acute intracerebral hemorrhage (ICH). Establish a cohort comprising 200 participants with cognitive impairment after robot-assisted neurosurgery treatment for ICH. Two hundred participants are randomly assigned to either an experimental group (n=100) or a control group (n=100). The experimental group receive conventional treatment and oral administration of Fufang Congrong Yizhi Capsules (FCYC) for 12 weeks, while the control group receive only conventional treatment. The object of the current study is 1) to observe the security and effectiveness of FCYC and 2) to decipher the contributing factors to cognitive impairment after robot-assisted neurosurgery treatment for intracerebral hemorrhage.
This description comes directly from the study's public registry record.
Qihui Zhang, MD. PhD · +86-10-67689749 · qihuizhang@vip.sina.com
Always discuss trial participation with your own doctor first.
| Second Affiliated Hospital of Tsinghua University | Beijing, Beijing Municipality, China | Recruiting |
| Qinhuangdao Hospital of Traditional Chinese Medicine | Qinhuangdao, Hebei, China | Recruiting |
| Kaifeng Third People's Hospital | Kaifeng, Henan, China | Recruiting |
| Shandong Public Health Clinical Center | Jinan, Shandong, China | Recruiting |
| Weifang Hospital of Traditional Chinese Medicine | Weifang, Shandong, China | Recruiting |
| Kunming Sanbo Brain Hospital | Kunming, Yunnan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06673602